Differential early humoral immune response in Lyme disease patients with chronic sequelae

Introduction Post-treatment Lyme disease syndrome (PTLDS) is a chronic illness that lacks validated biomarkers and is thought to be associated with the development of autoimmunity after the initial acute infection. High patient heterogeneity and potentially broad alterations in immune response in PTLDS represent a fundamental challenge and highlight the need for wide and unbiased interrogation of the immune response. High-dimensional antibody-binding platforms can pro le host humoral response beyond prede ned diagnostic antigens by measuring binding to large random peptide libraries and then projecting sequence-binding relationships onto microbial and human proteomes to infer immunogenic targets. Methods We applied this approach to longitudinal sera from patients with early Lyme disease, categorized as return to health (RTH), mild post-treatment Lyme disease syndrome (mPTLDS), or severe PTLDS (sPTLDS) following standard antibiotic therapy. Samples collected at diagnosis of erythema migrans (EM), at the end of 3 weeks of antibiotic treatment, and 6 and 12 months post-treatment were analyzed in two complementary ways: global binding to the random peptide library, which is not assigned to a specific antigen, and target-projected, computationally inferred binding to B. burgdorferi and human protein sequences. The three groups of patients differed in directly observed baseline global binding distributions and longitudinal kinetic clusters, and the downstream sequence projection analysis nominated cohort-associated B. burgdorferi protein families and candidate human protein sequence matches. Results and discussion The findings of this study suggest that PTLDS is associated with altered organization and persistence of antibody binding patterns, with target projection results providing hypotheses about possible antigen-family and host-protein associations. The results support broad antibody-repertoire pro ling as a framework for studying PTLDS and related post-acute infection syndromes.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.1934209
Primary Topic
Vector-borne infectious diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Differential early humoral immune response in Lyme disease patients with chronic sequelae

Nicole Baumgarth, Laimonas Kelbauskas, John N. Aucott, Alison W. Rebman et al.
4 links
Frontiers in Immunology
Vector-borne infectious diseases
article

Differential early humoral immune response in Lyme disease patients with chronic sequelae

Nicole Baumgarth, Laimonas Kelbauskas, John N. Aucott, Alison W. Rebman, Neal Woodbury, Tingting Zhang
article en

Abstract

Introduction Post-treatment Lyme disease syndrome (PTLDS) is a chronic illness that lacks validated biomarkers and is thought to be associated with the development of autoimmunity after the initial acute infection. High patient heterogeneity and potentially broad alterations in immune response in PTLDS represent a fundamental challenge and highlight the need for wide and unbiased interrogation of the immune response. High-dimensional antibody-binding platforms can pro le host humoral response beyond prede ned diagnostic antigens by measuring binding to large random peptide libraries and then projecting sequence-binding relationships onto microbial and human proteomes to infer immunogenic targets. Methods We applied this approach to longitudinal sera from patients with early Lyme disease, categorized as return to health (RTH), mild post-treatment Lyme disease syndrome (mPTLDS), or severe PTLDS (sPTLDS) following standard antibiotic therapy. Samples collected at diagnosis of erythema migrans (EM), at the end of 3 weeks of antibiotic treatment, and 6 and 12 months post-treatment were analyzed in two complementary ways: global binding to the random peptide library, which is not assigned to a specific antigen, and target-projected, computationally inferred binding to B. burgdorferi and human protein sequences. The three groups of patients differed in directly observed baseline global binding distributions and longitudinal kinetic clusters, and the downstream sequence projection analysis nominated cohort-associated B. burgdorferi protein families and candidate human protein sequence matches. Results and discussion The findings of this study suggest that PTLDS is associated with altered organization and persistence of antibody binding patterns, with target projection results providing hypotheses about possible antigen-family and host-protein associations. The results support broad antibody-repertoire pro ling as a framework for studying PTLDS and related post-acute infection syndromes.

Frontiers in ImmunologyVol. 17
Johns Hopkins University (US), Johns Hopkins Medicine (US), Arizona State University (US)
Good health and well-being
Vector-borne infectious diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon